Clear Health launches low-dose, more affordable Accutane acne treatment
Adult acne in women has risen by 10% over the last decade
Digital platform Clear Health has launched Microdose Accutance Protocol a low-dose, more affordable Accutane treatment aimed at milder forms of acne and to minimise side effects.
While acne is traditionally thought of as a ‘teenage disease’, adult acne is more common in women than men and adult acne in women has risen by 10% over the last decade.
Acne can cause mental distress at any age, including for adults where acne may be less normalised and feel more isolating.
Clear Health’s Danielle Samuels PhD said:
“We know that acne is far from a trivial cosmetic concern, because it can profoundly affect people’s mental health. Given that, we must shift the conversation to what we can do about it.
“One thing we can do is treat the acne, and remove unnecessary barriers to effective treatment, chief among them Accutane.”
While Accutane is a popular and effective FDA-approved treatment for acne, it can be expensive and it may also not be required in less severe cases. It can also cause side effects such as headaches and nosebleeds.
Clear Health’s low-dose, more affordable microdose protocol is an alternative.
Patients take part in a virtual medical evaluation and then the prescription can be delivered to their door.
The Microdose Accutane Protocol medication is $109 per month for 0.1-0.3mg/kg daily, taken over 18-24 months. This compares to the standard treatment cost of $400 per month for an in-office evaluation and 0.5-1.0mg/kg taken daily for six months.